Showing results (61-70 of 270) with videos related to
Sort By:
Pageof 27
American Journal of Clinical Pathology|July 18, 2015
Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results and Utility of Reflex ImmunohistochemistryKristen E Muller, Jonathan D Marotti, Vincent A Memoli, et al.Cancer|January 26, 2011
Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriersLarissa J Lee, Brian Alexander, Stuart J Schnitt, et al.International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancerMay Lim, Jennifer R Bellon, Rebecca Gelman, et al.International Journal of Surgery Case Reports|September 24, 2015
Recurrence of breast carcinoma as Paget disease of the skin at a prior core needle biopsy site: Case report and review of the literatureKatherina Zabicki Calvillo, Lifei Guo, Valerie Brostrom, et al.The Breast Journal|January 3, 2021
Encapsulated papillary carcinoma with and without frank invasion: Comparison of clinicopathologic features and role of axillary stagingChristopher R Jackson, Cameron C Felty, Jonathan D Marotti, et al.Journal of Neuro-Oncology|October 26, 2005
Acute monocular blindness resulting from transformation of von Recklinghausen's neurofibromatosis to malignant melanocytic schwannomasStephen H Wrzesinski, Konstantin H Dragnev, Lorna K Mayo, et al.Histopathology|May 22, 2014
Papillary and neuroendocrine breast lesions: the WHO stancePuay Hoon Tan, Stuart J Schnitt, Marc J van de Vijver, et al.The American Journal of Surgical Pathology|July 25, 2006
Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markersLaura C Collins, Victor P Carlo, Harry Hwang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysisElena B Elkin, Milton C Weinstein, Eric P Winer, et al.Cancer Causes & Control : CCC|February 11, 2018
Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?Nancy Krieger, Sheida Nabavi, Pamela D Waterman, et al.Pageof 27